Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Asparagine synthetase domain-containing protein 1 (ASNSD1)
- Target
- ASNSD1
- Molecular classification
- Other (Protein containing asparagine synthetase-like domain, but not confirmed as an enzyme or established functional protein family)
01
Overview
Asparagine synthetase domain-containing protein 1 (ASNSD1; also known as NS3TP1 or HCV NS3-transactivated protein 1) is a human protein encoded by the ASNSD1 gene. It is predicted to contain a domain similar to asparagine synthetase (the enzyme that catalyzes asparagine biosynthesis), but its enzymatic activity in human systems remains unconfirmed. The gene is expressed in various tissues, and extensive datasets associate it with functional or expression data, but there is no clear evidence that it functions as a receptor, transporter, enzyme, or classical therapeutic target. Alternative names include NBLA00058 and FLJ20752. Its precise biological role, if any, is currently not well characterized and it is not a recognized therapeutic target in the literature.
- Other names
- NS3TP1NBLA00058FLJ20752HCV NS3-transactivated protein 1
02
Biological functions
Unknown (Predicted to enable asparagine synthase (glutamine-hydrolyzing) activity, but biological functions are unconfirmed)
03
Disease associations
Other (Evidence for disease association is unestablished; not clearly linked to cancer, inflammation, neurodegenerative disease, or infection under current knowledge)
Beyond the preview
Go deeper on Asparagine synthetase domain-containing protein 1 (ASNSD1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asparagine synthetase domain-containing protein 1 (ASNSD1).